| Announce Date | 11/05/2025 |
| EPS Normalized Actual | $2169.21 (Beat by $2168.91) |
| EPS GAAP Actual | $2169.21 (Beat by $2168.91) |
| Revenue Actual | $0.391044B |
| Revenue Surprise | Beat by $391.044M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.45 |
| EPS GAAP Estimate | $0.45 |
| Revenue Estimate | $0.265334999B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 2.52 | 14.73 | 1.55442 | 4.35301 | 1 |
| Dec 2028 | 1.17 | 31.72 | 0.72335 | 1.83836 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.44 | 0.15 | 0.391044B | -49362.21% | 182.88M |
| FQ2 2025 (Jun 2025) | 0.15 | -0.12 | 0.204556B | 10.38% | -20.09M |
| FQ1 2025 (Mar 2025) | 0.48 | 0.48 | 0.31509B | 36.49% | 315.09M |
| FQ4 2024 (Dec 2024) | 2368.91 | 2368.91 | 274.572B | 99.91% | 274572M |
| FQ3 2024 (Sep 2024) | 2313.62 | 2313.62 | 193.419B | -42.42% | 193419M |
| FQ2 2024 (Jun 2024) | 0.27 | 0.27 | 0.183333B | -135.84% | 183.33M |
| FQ1 2024 (Mar 2024) | 0.24 | 0.24 | 0.200113B | -5.47% | 200.11M |
| FQ4 2023 (Dec 2023) | 1.35 | 1.35 | 0.240064B | -89.58% | 240.06M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0.45
Consensus Revenue Estimates
0.265334999B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.54 | -- | 0.34455 | 0.85163 | 1 |
| FQ3 2027 (Sep 2027) | 0.53 | -- | 0.33817 | 0.83585 | 1 |
| FQ2 2027 (Jun 2027) | 0.5 | -- | 0.31903 | 0.78854 | 1 |
| FQ1 2027 (Mar 2027) | 0.55 | -- | 0.35093 | 0.8674 | 1 |
| FQ4 2026 (Oct 2026) | 0.51 | -- | 0.32899 | 0.7045 | 1 |
| FQ3 2026 (Jul 2026) | 0.5 | 12 | 0.32254 | 0.69068 | 1 |
| FQ2 2026 (Jun 2026) | 0.46 | 67.39 | 0.27145 | 0.66335 | 1 |
| FQ1 2026 (Mar 2026) | 0.45 | -6.67 | 0.26555 | 0.64893 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.75B | -- | 0.54B | 1.08B | 2 |
| FQ3 2027 (Sep 2027) | 0.63B | -- | 0.45B | 0.91B | 2 |
| FQ2 2027 (Jun 2027) | 0.63B | -- | 0.45B | 0.91B | 2 |
| FQ1 2027 (Mar 2027) | 0.67B | -- | 0.48B | 0.97B | 2 |
| FQ4 2026 (Oct 2026) | 0.29B | -- | 0.21B | 0.37B | 1 |
| FQ3 2026 (Jul 2026) | 0.28B | -37.42 | 0.21B | 0.37B | 1 |
| FQ2 2026 (Jun 2026) | 0.27B | 23.73 | 0.18B | 0.36B | 2 |
| FQ1 2026 (Mar 2026) | 0.27B | -18.75 | 0.18B | 0.36B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.29 | 0.44 | 0.15 | 34.09% |
| FQ2 2025 (Jun 2025) | 0.27 | 0.15 | -0.12 | -80% |
| FQ1 2025 (Mar 2025) | 0.48 | 0.48 | 100% | |
| FQ4 2024 (Dec 2024) | 2368.91 | 2368.91 | 100% | |
| FQ3 2024 (Sep 2024) | 2313.62 | 2313.62 | 100% | |
| FQ2 2024 (Jun 2024) | 0.27 | 0.27 | 100% | |
| FQ1 2024 (Mar 2024) | 0.24 | 0.24 | 100% | |
| FQ4 2023 (Dec 2023) | 1.35 | 1.35 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.21B | $0.39B | $182.88M | 46.77% |
| FQ2 2025 (Jun 2025) | $0.22B | $0.2B | $-20.09M | -9.82% |
| FQ1 2025 (Mar 2025) | $0B | $0.32B | $315.09M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $274.57B | $274572M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $193.42B | $193419M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.18B | $183.33M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.2B | $200.11M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.24B | $240.06M | 100% |